Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 08, 2016 2:05 PM ET

Capital Markets

Company Overview of Sofinnova Partners

Company Overview

Sofinnova Partners is a venture capital and private equity firm specializing in incubation, early stage, seed/startups, post-startup, turnaround, corporate spin-off, and restart investments. It invests in companies in the healthcare, technology, and life sciences sectors. Within the technology sector, the firm seeks to invest in companies in sectors such as telecommunication, consumer electronics, wireless devices, Internet, wireless Internet, other technologies and markets such as energy and photonics, clean energy and technology including, green chemistry and bioenergy, and storage. Under the life sciences sectors, it invests in companies in the industrial biotechnologies, biopharmaceutica...

Immeuble le Centrorial

16 Rue du Quatre-Septembre

Paris,  75002


Founded in 1972


33 1 53 05 41 00


33 1 53 05 41 29

Key Executives for Sofinnova Partners

Managing Partner and Chairman
Age: 58
Managing Partner
Age: 49
Managing Partner and Chief Financial Officer
Managing Partner
Age: 46
Age: 46
Compensation as of Fiscal Year 2015.

Sofinnova Partners Key Developments

Sofinnova Partners Presents at Boston Biotech East West CEO Conference, Jan-10-2016 02:00 PM

Sofinnova Partners Presents at Boston Biotech East West CEO Conference, Jan-10-2016 02:00 PM. Venue: Four Seasons Hotel, 757 Market St., San Francisco, CA 94103, United States. Speakers: Daniel Welch.

Sofinnova Capital To Invest In Healthcare Industry

Sofinnova Partners announces its closing of Sofinnova Venture Partners VIII, L.P. at €300 million on December 8, 2015. Company announced that, "Pursuing the strategy it has consistently applied over the years, Sofinnova Capital VIII will invest in the healthcare industry and more specifically in the biopharmaceutical and medical device sectors. Sofinnova Partners will seek to invest as a founding and lead investor in start-ups and corporate spin-offs, and focus on therapeutic "paradigm shifting" technologies and products alongside visionary entrepreneurs. Sofinnova Capital VIII will invest about two thirds of its funds in European companies, and one third outside of Europe primarily in North America. This fund will leverage Sofinnova Partners' experienced international team. Based in Paris, the firm brings together 12 highly experienced investment professionals from all over Europe, the US and China."

Sofinnova Partners Presents at BIO Latin America Conference, Oct-16-2015 06:45 PM

Sofinnova Partners Presents at BIO Latin America Conference, Oct-16-2015 06:45 PM. Venue: Rio de Janeiro, Brazil. Speakers: Rafaèle Tordjman, Managing Partner.

Similar Private Companies By Industry

Company Name Region
OFG Recherche Europe
Mapa Mutuelle d'Assurance Europe
Médicis Partners SAS Europe
ASquare Finance Europe
Optivalue Europe

Recent Private Companies Transactions

Private Placement
February 3, 2016
Enyo Pharma S.A.S.
Private Placement
February 2, 2016
MISSION Therapeutics Ltd.
Private Placement
November 26, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sofinnova Partners, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at